Listed Company

Neuren Pharmaceuticals Limited (ASX NEU)


Followers 141
Exchange ASX
Sector Health Care
Industry Pharmaceuticals, Biotechnology & Life Sciences

Latest News on Neuren Pharmaceuticals Limited


Covering Neuren Pharmaceuticals Limited


Kerry Sun
Livewire Markets
Tom Wickenden
Betashares
Mark Gardner
MPC Markets
Ben Richards
Seneca Financial Solutions
Chris Prunty
QVG Capital
Glenn Freeman
Livewire Markets

Neuren Pharmaceuticals Limited (ASX:NEU) is an Australian publicly listed company that trades on the Australian Stock Exchange. The company's stock code is NEU. Livewire Markets has 23 experts who have published 57 articles that have featured Neuren Pharmaceuticals Limited. You can view all those wires here. The last time time NEU was featured was on the 03 August 2026 by Anthony Kavanagh in the wire “Return of the drug developer”. Get the latest NEU share price and other key information like NEU Financials on Market Index.

The 10th annual Livewire Live 2026

One room. One day. The minds that move markets.

22 September 2026 Art Gallery of NSW, Sydney

Register Now